J&J cell therapy gains edge over Bristol Myers rival

Jonathan Raa | Nurphoto | Getty ImagesThink a friend or colleague should be getting this newsletter? Share this link with them to sign up.Hi folks! Two competing cell therapies from Bristol Myers Squibb and Johnson & Johnson both got good news from the Food and Drug Administration on Friday. But...

Read more...

GM’s Cruise to relaunch vehicles with human drivers in Phoenix

A Cruise vehicle in San Francisco on Feb. 2, 2022.David Paul Morris | Bloomberg | Getty ImagesGeneral Motors' Cruise self-driving vehicle unit will redeploy cars on U.S. roadways Tuesday for the first time since October, beginning with a small fleet of human-driven vehicles in Phoenix, the company said.The relaunch...

Read more...

Boulder, Colorado, fosters a new generation of wellness entrepreneurs

Boulder is the No. 2 U.S. city for quality of life, according to U.S. News and World Report.Denistangneyjr | E+ | Getty ImagesThis story is part of CNBC's quarterly Cities of Success series, which explores cities that have transformed into business hubs with an entrepreneurial spirit that has attracted...

Read more...

Denver and its craft breweries embrace nonalcoholic beer, spirits

Denver Beer Co.Courtesy: Denver Beer Co.This story is part of CNBC's new quarterly Cities of Success series, which explores cities that have been transformed into business hubs with an entrepreneurial spirit that has attracted capital, companies and workers.Alcohol-free beverage options have skyrocketed over the past few years, and that...

Read more...

Pfizer RSV vaccine may protect high-risk adults ages 18-59

Respiratory syncytial virus - viral vaccine under researchHailshadow | Istock | Getty ImagesA vaccine from Pfizer showed the potential to protect adults ages 18 to 59 who are at increased risk of getting severely sick from respiratory syncytial virus in a late stage clinical trial, the company said Tuesday.The...

Read more...